Login

The Director and Co-Head of UK Corporate Finance at Houlihan Lokey specializes in the food & beverage sector, offering expert advisory services. 00:10:00

Share On Facebook Share On Twitter

Scott Beiser is a Co-Chairman of Houlihan Lokey

Recent Videos

00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences

Suggestions

00:10:00
The Struggle for Decent Politics: Liberalism and Democracy|Michael Walzer,Professor,Institute for Advanced Studies
00:10:00
Structured Notes Explained: Risk, Cost, and Fee Reduction Strategies | Craig Novorr - President and CIO of Paragon Capital Management, Ltd.
00:10:00
The Avellino Corneal Dystrophy test is available from Avellino Lab USA | Thomas Kim, PRESIDENT & CEO, AVELLINO LAB
00:10:00
Adam Melnick on Capital Resources' Strategic Growth in Copper Exploration
00:10:00
investing in big ideas and breakthrough discoveries|Bruno Faviero,General Partner,Alloy Fund
00:10:00
investment firm that focuses on cross-border financial investment|Michael Nicklas,Managing Partner,Valor Capital Group
00:10:00
Evolving Retail Real Estate: Insights from a Veteran Operator | Eric Sherman, Head of National Operations , First Capital REIT.
00:10:00
Navigating Financial Rules of Thumb: Personalizing Your Plan
00:10:00
Akobo Minerals Highlights 2023 Success and 2024 Plans with New Processing Plant and Underground Mine Progress
00:10:00
Redefining Growth Potential: Tech Sector Strategies Amid Economic Uncertainty | Denny Fish - Portfolio Manager | Research Analyst of Janus Henderson Investors
00:10:00
Vector Mining's Pursuit of World-Class Gold Assets in the DRC: Insights from CEO Simon
00:10:00
Maximizing Your Career as Your Most Valuable Asset | Michael Haubrich, CFP, from Financial Service Group Inc

© 2017 - Neuhu+